subacut
scleros
panenceph
sspe
rare
fatal
complic
measl
viru
infect
aris
year
acut
measl
chronic
diseas
process
characterist
measl
viru
inclus
present
cell
central
nervou
system
cn
freeman
et
al
connolli
et
al
ter
meulen
et
al
ter
meulen
et
al
patient
display
elev
serum
antibodi
titer
measl
viru
polypeptid
respons
includ
antimatrix
protein
activ
hall
choppin
stephenson
ter
meulen
respons
detect
consist
antibodi
remain
previou
acut
infect
hall
choppin
similar
pattern
observ
csf
antibodi
produc
also
lack
antimatrix
protein
activ
cn
howev
immunoglobulin
synthes
oligoclon
restrict
probabl
therefor
secret
lymphocyt
clone
invad
compart
epidemiolog
immunolog
current
knowledg
measl
viru
involv
recent
review
ter
meulen
et
al
sspe
infecti
viru
present
either
cn
tissu
prove
possibl
case
rescu
measleslik
viru
cocultiv
techniqu
review
agnarsdottir
virus
may
differ
measl
viru
singl
stabl
properti
differenti
fact
differ
variou
strain
measl
viru
similar
magnitud
observ
sspe
measl
virus
agnarsdottir
fraser
martin
experi
report
attempt
differenti
agent
use
monoclon
antibodi
rais
purifi
measl
viru
edmonston
case
isol
measl
viru
avail
acut
phase
infect
preced
develo
sspe
patient
attempt
model
event
vitro
use
tissu
cultur
vero
cell
persist
infect
sspe
viru
lec
compar
system
carrier
cultur
vitro
persist
infect
differ
vivo
persist
sinc
maintain
absenc
immun
respons
may
therefor
provid
insight
import
phenomenon
develop
sspe
measl
viru
edmonston
grown
vero
cell
describ
text
lec
sspe
viru
isol
cocultiv
techniqu
brain
child
sspe
barbantibrodano
et
al
persist
infect
lec
pi
establish
vero
cell
describ
ter
meulen
et
al
persist
infect
maintain
laboratori
two
year
immun
precipit
infect
cell
polypeptid
perform
use
cell
methioninelabel
lysat
prepar
h
p
edmonston
h
pi
lec
lytic
h
cell
passag
lec
pi
lysat
prepar
immunoprecipit
carri
ripa
buffer
ph
nacl
contain
sd
triton
sodium
deoxychol
describ
lamb
et
al
immunoprecipit
protein
analyz
polyacrylamid
gel
use
method
laemmli
visual
fluorographi
bonner
laskey
messeng
rna
isol
cellular
cytoplasm
fraction
select
oligo
dt
chromatographi
barrett
et
al
mrna
translat
reticulocyt
lysat
system
kindli
provid
dr
siddel
prepar
describ
pelham
jackson
modif
describ
siddel
et
al
prepar
monoclon
antibodi
radioimmunobind
assay
alreadi
describ
ter
meulen
et
al
serolog
assay
haemagglutin
inhibit
hai
neutral
nt
haemolysin
inhibit
hli
test
carri
describ
norrbi
gollmar
laboratori
prepar
hybridoma
antibodi
found
immunoprecipit
hpolypeptid
nucleocapsid
matrix
protein
measl
viru
edmonston
remaind
posit
techniqu
even
though
bound
high
titer
radioimmunoassay
biolog
properti
antihhybridoma
test
basi
antibodi
divid
group
ter
meulen
et
al
group
summar
tabl
type
analysi
provid
first
evid
given
antigen
determin
hpolypeptid
could
alter
function
signific
measl
sspe
viru
strain
site
given
antibodi
may
still
present
antibodyantigen
combin
longer
produc
biolog
effect
preliminari
data
direct
competit
h
p
use
hybridomaantibodi
immunoprecipit
polypeptid
lec
virusinfect
vero
cell
immunoprecipit
perform
vol
use
undilut
rabbit
serum
ascit
fluid
dilut
immun
complex
precipit
min
use
staphylococc
protein
coupl
sepharos
bead
arm
rabbit
antimous
immunoglobulin
dako
bind
experi
indic
group
occupi
least
partial
overlap
site
hprotein
molecul
two
antimatrix
protein
monoclon
appear
bind
distinct
site
protein
bind
mutual
exclus
character
npolypeptid
await
isol
monoclon
antibodi
panel
antibodi
use
comparison
lec
pi
cell
vero
cell
lytic
infect
lec
viru
immunoprecipit
fig
antimantibodi
found
immunoprecipit
mprotein
lytic
lec
infect
protein
immunoprecipit
doubl
band
also
observ
measl
viru
edmonston
infect
seem
therefor
mprotein
may
exist
two
relat
form
recent
rima
et
al
provid
evid
cleavag
product
measl
viru
pprotein
also
run
area
two
hybridoma
antibodi
also
precipit
protein
lec
pi
cell
lysat
owe
lower
level
viru
polypeptid
express
cell
line
much
higher
background
obtain
refer
control
monoclon
antibodi
rais
total
unrel
antigen
show
precipit
clearli
specif
antinucleocapsid
antibodi
react
n
protein
parent
lec
viru
form
persist
unabl
draw
conclus
regard
protein
antihaemagglutinin
hybridoma
antibodi
reveal
interest
effect
antibodi
use
clearli
posit
immun
precipit
reaction
test
antigen
produc
lytic
lec
viru
infect
antibodi
also
precipit
h
protein
lec
pi
cell
lysat
case
howev
monospecif
antibodi
precipit
h
polypeptid
doubl
band
h
h
current
peptid
map
studi
underway
clearli
establish
relationship
polypeptid
hybridoma
antibodi
name
borderlin
techniqu
view
high
background
difficult
definit
point
monoclon
antibodi
fail
definit
immunoprecipit
protein
lec
virusinfect
cell
lysat
use
immunofluoresc
test
provid
firm
evid
antigen
chang
persist
sinc
antibodi
fail
bind
lec
pi
cell
whilst
still
combin
well
antigen
present
cell
lytic
infect
lec
parent
viru
tableii
test
sensit
imunoprecipit
firm
antibodyantigen
combin
requir
thu
may
conclud
antigen
chang
arisen
cours
persist
infect
may
relat
doubl
band
observ
specif
immunoprecipit
hpolypeptid
lec
pi
cell
whether
latter
effect
due
differ
polypeptid
synthesi
modif
turnov
unclear
reason
also
attempt
decreas
nonspecif
precipit
background
phenomenon
examin
immunoprecipit
polypeptid
form
vitro
mrna
extract
lec
pi
cell
vero
cell
lytic
infect
lec
viru
addit
mrna
prepar
uninfect
cell
two
measl
viru
carrier
cell
line
cell
line
produc
cocultiv
techniqu
sspe
brain
materi
doi
et
al
agent
carri
cell
exclus
cellassoci
infecti
viru
never
detect
carrier
cell
line
origin
establish
norrbi
two
polypeptid
immunoprecipit
specif
translat
product
uninfect
cell
fig
track
u
u
translat
system
immunoprecipit
protein
product
absenc
ad
mrna
product
detect
fig
track
comparison
protein
form
lec
pi
lytic
lec
infect
cell
mrna
show
band
detect
h
protein
region
h
hi
mrna
lytic
infect
use
lec
pi
cell
mrna
translat
h
protein
precipit
lec
virusinfect
cell
lysat
observ
comigr
larger
compon
h
peptid
doublet
detect
lec
pi
cell
h
fig
vitro
translat
product
mrna
lec
pi
cell
comigr
lower
band
h
form
mrna
extract
vero
cell
lytic
infect
sspe
viru
lec
band
may
therefor
repres
precursor
fulli
modifi
h
protein
observ
fig
sinc
smaller
product
detect
amongst
vitro
translat
product
lec
pi
cell
split
h
band
h
h
fig
may
repres
posttransl
modif
polypeptid
h
fig
modif
either
occur
lytic
infect
cell
detect
extract
prepar
condit
higher
molecular
weight
protein
h
fig
present
understood
possibl
product
normal
rapidli
degrad
modifi
migrat
differ
posit
absenc
protein
translat
product
mrna
lec
pi
cell
howev
surpris
suggest
differ
viru
express
lytic
persist
infect
examin
might
due
phase
viru
replic
lec
pi
cell
fix
stage
normal
shortliv
lytic
infect
may
difficult
detect
translat
total
cellular
mrna
prolong
label
cellular
protein
relev
appar
differ
viru
express
antigen
differ
lytic
persist
infect
observ
tabl
present
unclear
analysi
mprotein
difficult
sinc
host
band
run
close
viru
posit
determin
lytic
infect
vero
cell
extract
protein
readili
detect
among
translat
product
virusreleas
carrier
lu
cell
mrna
present
also
lec
pi
protein
product
protein
detect
posit
nonviru
yield
cell
line
previou
commun
unabl
detect
lec
viru
protein
lec
pi
cell
note
product
among
protein
form
vitro
would
seem
result
explain
high
background
observ
fig
lb
problem
overcom
use
antimmonoclon
antibodi
consequ
reason
postul
translat
control
protein
lec
pi
cell
system
current
search
mrna
protein
cell
line
use
clone
cdna
copi
edmonston
mprotein
messag
protein
use
monoclon
antibodi
small
band
detect
fig
thought
breakdown
product
nucelocapsid
protein
report
observ
occurr
antigen
chang
sspe
viru
persist
observ
loss
abil
bind
monoclon
antibodi
evid
alter
viru
express
gather
seem
clear
rapid
mutat
drift
may
occur
viruspersist
vitro
holland
et
al
report
continu
evolut
virusspecif
rna
demonstr
vesicular
stomat
viru
persist
chang
manifest
product
small
plaqu
temperaturesensit
mutant
expect
sinc
may
suppos
effect
amino
acid
substitut
would
destabil
particular
protein
rel
would
lead
complet
loss
function
similar
situat
presum
exist
morbilliviru
persist
demonstr
chang
hprotein
antigen
sspe
viru
persist
absenc
antibodi
select
furthermor
product
small
plaqu
ts
mutant
measl
viru
persist
alreadi
well
document
ter
meulen
et
al
haspel
et
al
gould
linton
ju
et
al
moreov
ts
mutant
fail
complement
ts
revert
retain
small
plaqu
phenotyp
haspel
et
al
suggest
viru
accumul
number
differ
mutat
observ
measl
viru
releas
may
alter
time
persist
furthersupportsthisconcept
wechsleret
wildet
measl
viru
persist
vivo
possibl
compet
host
immun
respons
might
drive
mutat
viru
remain
onestep
ahead
host
virus
abl
mutat
easili
respons
monoclon
antibodi
true
influenza
laver
et
al
rabi
wiktor
koprowski
also
measl
viru
birrer
et
al
clearli
quit
easi
howev
evad
polyval
immun
respons
encount
vivo
import
context
emphas
sspe
virus
neutral
circul
antibodi
even
quit
sensit
measl
virus
payn
baubli
could
lead
condit
partial
neutral
conceiv
mutant
viru
might
abl
establish
persist
easili
second
role
antibodi
could
modul
antigen
express
antibodi
shown
directli
influenc
viru
antigen
express
cell
surfac
intracellularli
joseph
oldston
gould
almeida
fujinami
oldston
one
first
casualti
process
seem
express
viru
mprotein
evid
favour
event
vivo
observ
hamster
inocul
sspe
viru
infecti
viru
could
first
recov
gradual
becam
cellassoci
time
requir
process
could
lengthen
inocul
antilymphocyt
serum
thymectomi
byington
johnson
johnson
et
al
follow
intracerebr
inocul
hamster
express
protein
found
gradual
decreas
whilst
n
remain
high
johnson
et
al
final
sspe
patient
display
low
absent
immun
respons
protein
suggest
protein
longer
avail
immun
system
antigen
protein
detect
sspe
cell
line
imposs
rescu
viru
cell
line
similar
line
isol
thormar
et
al
mani
case
attempt
isol
viru
sspe
autopsi
materi
fail
wherea
instanc
cocultiv
techniqu
led
mprotein
product
viru
releas
thu
possibl
mechan
measl
viru
persist
may
differ
one
individu
anoth
within
differ
area
brain
summari
sspe
viru
lec
use
establish
persist
infect
vero
cell
late
passag
cultur
shed
detect
infecti
viru
compar
lytic
lec
viru
infect
use
monoclon
antibodi
immun
precipit
immun
fluoresc
reaction
data
indic
haemagglutinin
molecul
h
undergon
antigen
chang
viru
persist
vitro
antigen
chang
matrix
protein
detect
lec
persist
infect
compar
carrier
cultur
measl
viru
carrier
lu
cell
sspe
agent
ni
vitro
translat
extract
mrna
relev
observ
mechan
viru
persist
sspe
discuss
